本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kalvista Pharmaceuticals Inc

13.77
+0.69005.28%
盤後13.800.0300+0.22%17:04 EDT
成交量:87.85萬
成交額:1,194.93萬
市值:6.85億
市盈率:-3.70
高:14.00
開:13.06
低:12.90
收:13.08
資料載入中...
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/29

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/12/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/29

重要事件披露

Form 8-K - Current report
2023/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/08

重要事件披露

Form 8-K - Current report
2023/09/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/10

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/07/10

重要事件披露

Form 8-K - Current report
2023/06/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/14

重要事件披露

Form 8-K - Current report
2023/03/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]